PDCD1 and neoplasm: Furthermore, ES@CuO can stimulate immune responses via increased tumor-infiltrating T lymphocytes and inflammatory cytokine secretion, thereby significantly enhancing the anti-tumor efficacy of anti-PD-1 antibodies in mouse melanoma (Lu X. et al., 2024).